TC
ZBH icon

Tavio Capital’s Zimmer Biomet ZBH Stock Holding History

Tavio Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-131,654
Closed -$15.3M – 7
2020
Q2 		$15.3M Buy
131,654
+57,246
+77% +$6.6M 20.22% 3
2020
Q1 		$7.3M Sell
74,408
-225,313
-75% -$29.5M 10.54% 5
2019
Q4 		$43.6M Buy
299,721
+6,662
+2% +$920K 16.06% 1
2019
Q3 		$39.1M Sell
293,059
-64,618
-18% -$8.35M 20.64% 1
2019
Q2 		$40.9M Sell
357,677
-33,493
-9% -$3.92M 16.59% 1
2019
Q1 		$48.5M Buy
391,170
+124,282
+47% +$14.1M 17.87% 1
2018
Q4 		$26.9M Buy
266,888
+21,042
+9% +$2.37M 11.16% 4
2018
Q3 		$31.4M Buy
+245,846
New +$29.2M 12.24% 2

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Tavio Capital's ZBH Position: Q3 2020 in Review

Tavio Capital sold out of Zimmer Biomet (ZBH) in Q3 2020, closing a stake of 131,654 shares — an estimated $15.3M sold.

Tavio Capital first reported a position in ZBH in Q3 2018 and held it in 8 quarters. The position peaked at $48.5M in Q1 2019. 930 funds tracked by Wall St. Rank hold ZBH as of Q3 2020.

  • Tavio Capital reported no remaining Zimmer Biomet position as of Q3 2020 after selling out during the quarter.
  • Tavio Capital sold 131,654 Zimmer Biomet shares in Q3 2020, an estimated $15.3M.
  • Tavio Capital first reported a position in Zimmer Biomet in Q3 2018 and held it in 8 quarters.
  • Tavio Capital's Zimmer Biomet position peaked at $48.5M in Q1 2019.
  • 930 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2020.

Based on Tavio Capital's 13F filing for Q3 2020.